Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Cell Culture PD - Parallel System for Cell Culture Process Development

Product Image
Product Description

DASGIP Parallel Bioreactor Systems for process development with animal and insect as well as with human cell lines allow for advanced process control and automation.

Precise control of all relevant process parameters, user-defined profiles and innumerable automation features result in accelerated and highly efficient process development. Industry-leading communication standards support DoE, process historians and comprehensive data management.

Individual systems can be configured with assorted components and software functions to meet specific application requirements:

  • Parallel operation of four, eight or sixteen bioreactors
  • Excellent growth of e.g. CHO, Hybridoma and NS0 cell lines
  • Excellent scalability and reproducibility
  • Support of high cell densities up to 2x10^7 cells per mL
  • Small footprint achieved through using compact stackable modules
  • Predefined recipes for standard applications
  • Full controller scripting for easy scale-up and scale-down
  • Variable speed pump drives
  • Continuous and cyclic perfusion templates
  • Overhead drives
  • Individual temperature control via Heating Blanket and/or Cooling Finger
  • pH control using acid and base or CO2 and base
  • pO2 control with constant gassing or gassing on demand
  • Individual gas mixture from Air, O2, CO2 and N2
  • Thermal Mass Flow controlled gassing
  • Cascaded pO2 control using gas flow rates and oxygen enchrichment
  • Gassing to headspace, sparger and/or overlay
  • Level control and/or anti foam sensor
  • Optional integration to bioprocess analyzer, cell counter, HPLC, etc.
  • In-situ cell growth monitoring (optical density)
Product Cell Culture PD - Parallel System for Cell Culture Process Development
Company DASGIP
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Rudolf-Schulten-Str. 5 52428 Jülich Germany

Tel: +49 (0)2461-980-0


Scientific News
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Tissue Engineers Recruit Cells to Make Their Own Strong Matrix
Extracellular matrix is the material that gives tissues their strength and stretch. It’s been hard to make well in the lab, but a Brown University team reports new success. The key was creating a culture environment that guided cells to make ECM themselves.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Artificial Kidney Research Gets A Boost
Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost.


SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos